Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Recruiting × Clinical Protocols × Clear all

Phase

Phase 2 4 Phase EARLY_PHASE1 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Interventions

Cyclophosphamide 14 Magnetic Resonance Spectroscopy 12 fludarabine 11 pembrolizumab 8 Specimen Handling 8 Radiotherapy 5 Paclitaxel 5 Immunotherapy, Adoptive 5 Fluorodeoxyglucose F18 5 Immune Checkpoint Inhibitors 4 Cisplatin 4 Carboplatin 4 ruxolitinib 3 lenvatinib 3 fluciclovine F-18 3 X-Rays 3 Temozolomide 3 Surgical Procedures, Operative 3 Etoposide 3 Doxorubicin 3 Dexamethasone 3 Dasatinib 3 Cholecalciferol 3 68Ga-FAPI 3 venetoclax 2 tislelizumab 2 temsirolimus 2 olaparib 2 daratumumab 2 aldesleukin 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05141474 2024-11-07

NEXTGENTIL-ACT

Vall d'Hebron Institute of Oncology

Phase EARLY_PHASE1 Recruiting

Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡